Granulocytes should be transfused ABO- and Rhesus-compatible as there is always a significant RBC contamination. If the recipient is cytomegalo virus-negative concentrates from cytomegalo ...

Patients with neutropenia who have multidrug-resistant organisms have better rates of overall survival when receiving granulocyte transfusions within 7 days of neutropenic sepsis. Patients with ...

Neutropenia-related infection is a major factor contributing to morbidity and mortality in patients with hematologic malignancy despite appropriate antibiotic therapy.1 2 3 Although the use of ...

Researchers in Sweden have provided a comprehensive characterization of circulating granulocytes in people infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that ...

The serum muramidase activities of four granulocytopenic patients with the Chediak—Higashi syndrome were always strikingly elevated, indicating a markedly increased rate of granulocyte turnover. Two ...

Treatment of newly diagnosed acute promyelocytic leukemia without cytarabine. In our previous study with MACOPB, we identified a high-risk group of patients with a poor 3-year survival rate of 29%.

Phase II Study of Dose-Adjusted EPOCH and Rituximab in Untreated Diffuse Large B-Cell Lymphoma With Analysis of Germinal Center and Post-Germinal Center Biomarkers We hypothesized that ...

Immature ganulocytes, also called myeloblasts, are a type of young white blood cell. Unusual amounts of myeloblasts usually occur due to problems with bone marrow, such as certain types of blood ...

Although currently underutilized, granulocyte colony-stimulating factor prophylaxis as supportive cancer care provides substantial value to society. Aligning utilization with clinical guidelines would ...

Bacterial and fungal infections are the main cause of morbidity and mortality in neutropenic patients. The transfusion of granulocytes to restore host defenses in severely neutropenic patients has ...